DayOne, the Healthcare Innovation initiative based in Switzerland, announces the extended deadline for the global call for its digital health accelerator to Friday, 5 November 2021.
Startups with a focus on pain therapy can apply to be considered for the DayOne Accelerator by 5 November 2021. DayOne is looking for companies with emerging technologies for pain treatment as well as digital healthcare solutions in pain management.
The DayOne Accelerator is the healthcare innovation initiative of Basel Area Business & Innovation and is split into three categories: Digital Health, Tech and Innovation Booster. They support promising new digital health and precision medicine ventures with guidance, mentorship, funding and collaborative workspaces. From 2018, DayOne has supported 20 companies with a combined valuation of over CHF 65 million, contributing to the life sciences ecosystem of the Basel Area. DayOne has helped launch, connect and mentor a number of innovative healthcare ventures, which include companies such as Zoundream and Nutrix in addition to others in medtech, medical device, digital health, AI, nutrition, health monitoring, medical access and more.
Building on this success, the DayOne Accelerator is extending its offering – both in terms of content and the area it covers. Going forward, DayOne is opening its accelerator to startups operating in practically all areas of digital health. It will also expand its financial support to allow companies in the fields of prevention, diagnostics and treatment to apply for grants as well.
For the Digital Health track, three startups will be considered for the three-month funding program, with each in line to receive a grant of up to CHF 45,000 in funding and services in addition to expert coaching and access to the world leading biopharma ecosystem of the Basel Area.
"At DayOne, we believe that the future of health can only evolve if advances in medical and healthcare technologies go hand in hand with innovation across the ecosystem. Today innovation primarily takes place within separate silos, where pharmaceutical companies, healthcare providers and governments have different agendas. Bringing all these areas together in a neutral setting of collaboration is the key to shaping the future of health, building an innovation hub. We are delighted to launch these new calls to encourage innovation in digital health and support entrepreneurs realise their vision while providing much needed solutions for patients."
Lucas Scherdel, Director Healthcare Innovation – DayOne
DayOne is also announcing calls for its Tech and Innovation Booster verticals, with deadlines in Q1 2022. For the Tech vertical, the focus is on startups in medical robotics, 3D printing, virtual reality in healthcare applications and technological solutions for personalized medicine. The winners will receive financial support of up to CHF 100,000 in funding and services, amongst other benefits including offering of shared offices and access to a world leading medtech and microtechnology network.
Finally, the Innovation Booster category supports budding projects in the area of digital health. The focus here is on patient-centric solutions that have been jointly developed by startups in close collaboration with academic partners and Big Pharma. The Innovation Booster category is operated on a nationwide basis, with startups able to submit applications in the first quarter of 2022.
In addition to financing support, DayOne helps build out companies and teams from inception to a point where they can raise financing and enter strategic collaborations. Harnessing the Basel Area's unique position as a global healthcare hub, as well as its rising popularity among investors, DayOne is looking to attract the next generation of breakthrough companies. Interested groups can find information at www.dayone.swiss/digitalhealth.
DayOne accelerates innovative ventures across three verticals:
Digital Health: Pain management track starts Jan 2022 – apply by Nov 5, 2021
Tech: Ventures in medical robotics, virtual reality for healthcare or personalized medical technologies – call opens Q1 2022
Innovation Booster: Empowered by Innosuisse, with a special focus on the interface with big pharma and academia – call opens Q1 2022
About DayOne Accelerator
At DayOne, we are shaping the future of health by accelerating digital transformation in Europe's leading healthcare and life sciences hub. As the Healthcare Innovation initiative by Basel Area Business & Innovation, DayOne believes in a patient-centric and sustainable approach to healthcare. Led by a team of industry experts, medical doctors, tech enthusiasts and researchers, the DayOne innovation hub serves a growing community of 2,000+ healthcare innovators throughout the Basel Area life sciences and healthcare ecosystem. The DayOne Accelerator boosts innovative ventures that combine groundbreaking technologies, healthcare expertise, and entrepreneurial spirit. Since 2018, the DayOne Accelerator has supported 20 companies, with a combined valuation of over CHF 65 million.
About Basel Area Business & Innovation
Basel Area Business & Innovation is the investment and innovation promotion agency dedicated to helping companies, institutions and startups find business success in the Basel Area, Switzerland. The organization targets and attracts companies to settle, supports founders of innovative ventures, and drives high growth initiatives in order to establish the region as the Swiss business and innovation hub of the future. The non-profit agency focuses on growing the area's cutting-edge industries life sciences, healthcare and production technologies.
FUTURE OF HEALTHCARE
Mpowered Health, a consumer health empowerment company, today announced a partnership with eHealth, Inc., a leading online health insurance marketplace.
Through its partnership with eHealth, Mpowered Health's consumers who include seniors, uninsured and underinsured families, can now review, compare, and enroll in a broad selection of plans, with access to tools that will help them find plans covering their preferred doctors and personal prescription drug needs at the lowest price.
"Our vision is to provide consumers the convenience, choice, transparency and access they need to make better healthcare decisions for themselves and their families. Providing a convenient, personalized coverage purchasing experience is aligned with this vision. We are pleased to partner with eHealth in bringing this convenience to our consumers."
Nandini Devi, Founder & CEO, Mpowered Health
"Mpowered Health's commitment to promoting market transparency and empowering consumers makes it a natural partner for eHealth," said John Connor, eHealth's Vice President and General Manager of Strategic Partnerships. "At eHealth, we're dedicated to serving the needs of all health insurance consumers, from individuals and families to Medicare beneficiaries, by helping them find the very best coverage for their personal needs and budget. We're excited to work with Mpowered Health toward that goal."
Prior to founding Mpowered Health, Nandini co-founded ZeOmega and helped scale it into one of the largest population health management solutions companies in the industry.
Nandini founded Mpowered Health in February 2019 as a bold move intended to give consumers a voice, the transparency, the choice, the access and the convenience they need to manage their own and their family's healthcare from birth to end-of-life.
About Mpowered Health
Mpowered Health is a consumer-driven healthcare technology company committed to creating a better healthcare experience for consumers and enterprises. The California-based company empowers consumers to take charge of their healthcare by providing mobile-led solutions that improve transparency, choice, access and convenience.
eHealth, Inc. operates a leading health insurance marketplace at eHealth.com and eHealthMedicare.com with technology that provides consumers with health insurance enrollment solutions. Since 1997, eHealth has connected more than 8 million members with quality, affordable health insurance, Medicare options, and ancillary plans. eHealth's proprietary marketplace offers Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual, family, small business and other plans from over 200 health insurance carriers across 50 states and the District of Columbia.
Medical device and AI company OPUM has partnered with Habit Health, New Zealand’s largest integrated health, fitness and physiotherapy rehabilitation provider, to improve patient outcomes. Habit Health will use OPUM’s expertise to support and optimize clinical decision making while delivering cost efficiencies over the course of patients’ care journeys.OPUM’s partnership with Habit Health leverages OPUM LabTM predictive AI models to guide recovery from injury and progress through the care pathway. The AI algorithms, based on a decade of research, help optimize care planning to achieve the best possible outcomes. Using clinical triage tools, OPUM LabTM predicts patient complexity on the first visit, assesses therapy needs and identifies patients who would benefit from surgery. The algorithms provide the clinical team with another piece of clinical reasoning to complement the interdisciplinary team assessment.
“The insights delivered by this world-leading technology will enable us to deliver a step-change in personalized care and better support people in their communities to optimize health and live their best lives,” says Mark Shirley, Clinical Innovation Executive at Habit Health.
“With widespread availability of online medical information, patients now expect their care providers to be delivering more value, for example by offering a higher level of personalized care and a better overall care experience. In the rapidly evolving healthcare technology landscape insurers are also requiring increased levels of evidence from providers to prove their interventions are justified and effective.”
OPUM CEO and Associate Professor Andrew McDaid
OPUM empowers providers to deliver scalable, personalized musculoskeletal care to positively impact the lives of patients around the world. Professor Andrew McDaid adds; “This partnership is a key milestone towards our vision to become the world’s largest and most trusted musculoskeletal knowledge base.”
Accident Compensation Corporation (ACC), New Zealand’s only accident compensation scheme, has co-designed the Escalated Care Pathways (ECP) with Habit Health and other care providers, aiming to improve access and equity and to enhance outcomes following back, knee and shoulder injuries.
“Escalated Care Pathways offer a streamlined approach to providing integrated and optimized care journeys. They are designed to encourage innovation in the care journey. We look forward to seeing the impact on patient outcomes through evidence-based decision making that this partnership between OPUM and Habit Health aims to achieve,” says Fraser Wilkins from ACC.
OPUM empowers patients, providers and payers to conquer musculoskeletal health challenges by surfacing actionable insights that enable better decision making. OPUM’s AI-driven platform enables optimal care to be delivered in a scalable way. OPUM is a venture backed medical device and AI company formed off the foundation of a decade of world-leading medical device research at the University of Auckland. The Digital Knee® product range was launched in the US in September 2020 and is available through leading physicians.
About Habit Health
Habit Health is New Zealand's largest integrated health, fitness and physiotherapy rehabilitation provider. An extensive range of specialized health, fitness and personal welfare services along with a comprehensive national footprint, allows Habit Health to optimize the health and wellbeing of Kiwis at home, in the workplace or at one of more than 100 locations. Habit Health support people in their communities to optimize health and live their best lives.